FDA Application
-
NDC Search Results on Active Ingredient: aspirin
Click on Active Ingredient to view the label.
Ingredient Name | NDC | Company Name | Application Number or Regulatory Citation | Product Type | Marketing Category |
---|---|---|---|---|---|
DIPHENHYDRAMINE HYDROCHLORIDE; ACETAMINOPHEN; ASPIRIN; CAFFEINE | 73006-350-98 | O4 Global Trading Usa, Llc | part338 | HUMAN OTC DRUG | OTC monograph final |
ACETAMINOPHEN; ASPIRIN; CAFFEINE | 69729-055-40 | OPMX LLC | M013 | HUMAN OTC DRUG | OTC Monograph Drug |
ASPIRIN | 69729-104-12 | OPMX LLC | part343 | HUMAN OTC DRUG | OTC monograph not final |
ACETAMINOPHEN; ASPIRIN; CAFFEINE | 69729-159-12 | OPMX LLC | M013 | HUMAN OTC DRUG | OTC Monograph Drug |
ASPIRIN; ACETAMINOPHEN; CAFFEINE | 69729-601-24 | OPMX LLC | M013 | HUMAN OTC DRUG | OTC Monograph Drug |
ASPIRIN; ACETAMINOPHEN; CAFFEINE | 69729-105-24 | OPMX LLC | part343 | HUMAN OTC DRUG | OTC monograph not final |
ASPIRIN | 59726-227-03 | P & L Development, LLC | part343 | HUMAN OTC DRUG | OTC monograph not final |
ACETAMINOPHEN; CAFFEINE; ASPIRIN | 59726-525-50 | P & L Development, LLC | part343 | HUMAN OTC DRUG | OTC monograph not final |
CAFFEINE; ACETAMINOPHEN; ASPIRIN | 59726-011-50 | P & L Development, LLC | M013 | HUMAN OTC DRUG | OTC Monograph Drug |
ASPIRIN | 59726-867-10 | P & L Development, LLC | M013 | HUMAN OTC DRUG | OTC Monograph Drug |
ASPIRIN | 59726-065-30 | P & L Development, LLC | M013 | HUMAN OTC DRUG | OTC Monograph Drug |
ASPIRIN | 59726-227-10 | P & L Development, LLC | part343 | HUMAN OTC DRUG | OTC monograph not final |
ACETAMINOPHEN; CAFFEINE; ASPIRIN | 59726-525-24 | P & L Development, LLC | part343 | HUMAN OTC DRUG | OTC monograph not final |
ASPIRIN | 59726-867-60 | P & L Development, LLC | M013 | HUMAN OTC DRUG | OTC Monograph Drug |
ASPIRIN | 59726-867-30 | P & L Development, LLC | M013 | HUMAN OTC DRUG | OTC Monograph Drug |
ASPIRIN; ACETAMINOPHEN; CAFFEINE | 59726-865-50 | P & L Development, LLC | part343 | HUMAN OTC DRUG | OTC monograph not final |
ASPIRIN | 59726-227-60 | P & L Development, LLC | part343 | HUMAN OTC DRUG | OTC monograph not final |
ASPIRIN | 62309-777-01 | Pace Wellness Inc. | part343 | HUMAN OTC DRUG | OTC MONOGRAPH FINAL |
ASPIRIN | 62309-779-01 | Pace Wellness Inc. | part343 | HUMAN OTC DRUG | OTC MONOGRAPH FINAL |
ASPIRIN | 62309-779-02 | Pace Wellness Inc. | part343 | HUMAN OTC DRUG | OTC MONOGRAPH FINAL |
ASPIRIN | 0574-7034-12 | Padagis US LLC | part343 | HUMAN OTC DRUG | OTC monograph not final |
ASPIRIN | 0574-7036-12 | Padagis US LLC | part343 | HUMAN OTC DRUG | OTC monograph not final |
DIPYRIDAMOLE; ASPIRIN | 49884-007-02 | Par Pharmaceutical, Inc. | ANDA207944 | HUMAN PRESCRIPTION DRUG | ANDA |
ADENOSINE TRIPHOSPHATE DISODIUM; GALIUM APARINE; NIACINAMIDE; RIBOFLAVIN; BACILLUS ANTHRACIS IMMUNOSERUM RABBIT; PANTOTHENIC ACID; SODIUM DIETHYL OXALACETATE; PODOPHYLLUM PELTATUM ROOT; SALMONELLA ENTERICA SUBSP. ENTERICA SEROVAR ENTERITIDIS; BILBERRY; CONIUM MACULATUM FLOWERING TOP; UBIDECARENONE; SULFUR; PYRIDOXINE HYDROCHLORIDE; COLCHICUM AUTUMNALE BULB; .ALPHA.-LIPOIC ACID; NADIDE; MAGNESIUM GLUCONATE; THIAMINE HYDROCHLORIDE; GOLDENSEAL; MANGANESE PHOSPHATE, DIBASIC; LACTIC ACID, L-; NOREPINEPHRINE; HYDROQUININE; HISTAMINE DIHYDROCHLORIDE; ASPIRIN; ASCORBIC ACID; 1,4-NAPHTHOQUINONE | 70321-0003-1 | Parasitology Center Inc. | HUMAN OTC DRUG | unapproved homeopathic | |
ASPIRIN | 72789-039-98 | PD-Rx Pharmaceuticals, Inc. | M013 | HUMAN OTC DRUG | OTC Monograph Drug |
ASPIRIN | 72789-039-01 | PD-Rx Pharmaceuticals, Inc. | M013 | HUMAN OTC DRUG | OTC Monograph Drug |
ASPIRIN | 72789-039-35 | PD-Rx Pharmaceuticals, Inc. | M013 | HUMAN OTC DRUG | OTC Monograph Drug |
ASPIRIN | 43063-862-90 | PD-Rx Pharmaceuticals, Inc. | M013 | HUMAN OTC DRUG | OTC Monograph Drug |
ASPIRIN | 27102-131-05 | Petco | OTC ANIMAL DRUG | unapproved drug other | |
ASPIRIN | 27102-130-06 | Petco | OTC ANIMAL DRUG | unapproved drug other |
-